The US Centers for Medicare and Medicaid Services (CMS) has granted a New Technology Add-on Payment for Medtronic’s IN.PACT Admiral drug-coated balloon under the Medicare hospital inpatient prospective payment system.
Hans van Overhagen and Jim A Reekers from The Netherlands have authored the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Standard of Practice guidelines for transcatheter uterine artery embolization (UAE) for symptomatic leiomyomata and these have been published in Cardiovascular and Interventional Radiology (CVIR). The authors urge that every symptomatic patient with uterine myomas should be offered embolization as alternative treatment to hysterectomy/myomectomy. "UAE should be incorporated in the (national) gynaecological guidelines," they report.
Researchers at the University of Cambridge, in collaboration with the University of Edinburgh, have shown how a radioactive agent developed in the 1960s to detect bone cancer can be repurposed to highlight the build-up of unstable calcium deposits in arteries.
After the European launch in April 2015, Biolas has introduced the VariClose Vein Sealing Systems in the European market for the treatment of varicose veins.
Kem Hawkins, president of Cook Group Incorporated, retired on July 1 after 34 years with the Cook organisation. Hawkins will remain on the board of directors for Cook Group. Pete Yonkman, current president of Cook Medical, has been chosen as Hawkins’ successor as president of Cook Group.
Carestream Health entered the radiography/fluoroscopy market with two systems that deliver high-quality, cost-effective imaging: the Carestream DRX-Excel Carestream DRX-Excel Plus.
Hospitals often overestimate their performance in providing fast delivery of anti-clotting medication to stroke patients, according to new research in the Journal of the American Heart Association.
Each year, nearly 40,000 Americans undergo elective surgery to repair an abdominal aortic aneurysm (AAA) with the goal of preventing a life-threatening rupture of this potentially dangerous cardiovascular condition. A new study from researchers at Beth Israel Deaconess Medical Center, Boston, USA, compared open surgical repair with a catheter-based procedure and found that the less invasive endovascular aortic repair (EVAR) has clear benefits for most patients, providing both a safer operation and a quicker recovery. The study was published in The New England Journal of Medicine.
Metactive announced that it has received a phase I National Institutes of Health (NIH) grant to fund comparative studies of its embolization device, Blockstent microcatheter.
Preclinical research published online ahead of print in the Journal of Vascular and Interventional Radiology (JVIR) in July shows that combretastatin A4 is a stronger inhibitor of the smooth muscle cell cycle than sirolimus or paclitaxel. Thus, it may represent an alternative coating for drug-eluting stents and balloons in atherosclerotic luminal stenosis, the investigators write.
Results from the 9th Annual Survey on Observational Research conducted by Continuum Clinical suggest that the pharmaceutical, biotech, and medical device industries are aware of the benefits of observational research in better understanding the real world value of their products. However, they also show that there is continued need to improve the design and implementation of the studies.
Guerbet has announced entering into a definitive agreement under which it will acquire Mallinckrodt’s contrast media and delivery systems business in its entirety for approximately US$270 million. With this acquisition, Guerbet aims to create a new global leader in medical imaging.
Two new studies presented at the Society of NeuroInterventional Surgery 12th Annual Meeting in San Francisco, USA, report that Mobile Stroke Treatment Units (MSTUs) can significantly reduce the time it takes to diagnose and treat patients for stroke, greatly improving survival rates and enhancing a patient’s chance of recovery.
The US Food and Drug Administration (FDA) has consented to the initiation of the clinical study for the new Gore Excluder conformable abdominal aortic aneurysm endoprosthesis, and the Japanese clinical trial notification for the new device was accepted by Japan’s Pharmaceuticals and Medical Devices Agency.
Gore is making available an educational compendium of presentations and discussions from the inaugural Gore-sponsored Surgical Bypass Summit to promote knowledge sharing around this topic. The content is now available at www.surgicalbypass.com. The event co-chairs, Richard Neville and Russell Samson, along with a global group of vascular surgeons, are leading an effort to revisit treatment paradigms for the continual improvement of patient care, an initiative which was at the front of mind at the 2015 Society for Vascular Surgery Annual Meeting (17–20 June, Chicago, USA).
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos